Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-11 Sale | 2025-11-13 7:01 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 119,524 | $44.88 | $5,363,716 | 272,212 (Direct) | View |
| 2025-11-11 Sale | 2025-11-13 7:01 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 200,000 | $45.44 | $9,088,499 | 631,305 (Direct) | View |
| 2025-11-13 Sale | 2025-11-13 7:01 pm | Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director | 15,000 | $45.99 | $689,797 | 17,900 (Direct) | View |
| 2025-11-11 Sale | 2025-11-13 7:01 pm | Mineralys Therapeutics Inc. | MLYS | Gold Alexander M Director | 34,675 | $45.45 | $1,576,095 | 71,092 (Direct) | View |
| 2025-10-13 Sale | 2025-10-15 7:04 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 10,758 | $42.01 | $451,984 | 116,865 (Direct) | View |
| 2025-10-13 Sale | 2025-10-15 7:04 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 15,100 | $42.67 | $644,327 | 831,305 (Direct) | View |
| 2025-10-15 Sale | 2025-10-15 7:04 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 10,369 | $43.01 | $445,982 | 71,155 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 6:54 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,367 | $36 | $409,266 | 81,524 (Direct) | View |
| 2025-09-04 Purchase | 2025-09-08 8:07 pm | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Director | 588,235 | $25.5 | $14,999,993 | 6,263,151 (Indirect) | View |
| 2025-09-04 Purchase | 2025-09-08 5:59 pm | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 1,176,470 | $25.5 | $29,999,985 | 7,323,750 (Indirect) | View |
| 2025-08-13 Sale | 2025-08-14 6:02 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,365 | $12.93 | $146,987 | 175,422 (Direct) | View |
| 2025-07-28 Sale | 2025-07-30 8:12 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 73,678 | $14.62 | $1,077,477 | 132,934 (Direct) | View |
| 2025-07-11 Sale | 2025-07-15 5:02 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 15,884 | $14.51 | $230,431 | 846,405 (Direct) | View |
| 2025-07-11 Sale | 2025-07-15 5:01 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 10,758 | $14.45 | $155,454 | 206,612 (Direct) | View |
| 2025-07-14 Sale | 2025-07-15 5:00 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $14.59 | $165,879 | 186,787 (Direct) | View |
| 2025-06-13 Sale | 2025-06-16 4:03 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $14.6 | $165,931 | 196,880 (Direct) | View |
| 2025-05-14 Sale | 2025-05-15 7:01 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $15.29 | $173,774 | 106,669 (Direct) | View |
| 2025-03-13 Purchase | 2025-04-25 7:01 pm | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 259,259 | $13.5 | $3,499,997 | 8,903,838 (Indirect) | View |
| 2025-04-14 Sale | 2025-04-15 8:39 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $14.53 | $165,185 | 219,612 (Direct) | View |
| 2025-04-11 Sale | 2025-04-15 8:36 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 10,757 | $12.06 | $129,684 | 215,340 (Direct) | View |
| 2025-04-11 Sale | 2025-04-15 8:33 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 15,319 | $12.19 | $186,803 | 862,289 (Direct) | View |
| 2025-04-01 Sale | 2025-04-03 5:36 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 55,771 | $15.76 | $879,008 | 230,978 (Direct) | View |
| 2025-03-13 Purchase | 2025-03-17 9:05 pm | Mineralys Therapeutics Inc. | MLYS | Samsara BioCapital GP LLC Samsara BioCapital L.P. 10% Owner | 600,000 | $13.5 | $8,100,000 | 5,674,916 (Indirect) | View |
| 2025-03-13 Purchase | 2025-03-17 9:04 pm | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Director | 600,000 | $13.5 | $8,100,000 | 5,674,916 (Indirect) | View |
| 2025-03-13 Purchase | 2025-03-17 7:56 pm | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 1,296,296 | $13.5 | $17,499,996 | 6,147,280 (Indirect) | View |
| 2025-01-13 Sale | 2025-01-15 9:46 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 10,757 | $9.0977 | $97,864 | 226,097 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-11-11 Exercise | 2025-11-13 7:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 34,414 | $16 | 272,212 (Direct) | View |
| 2025-11-11 Exercise | 2025-11-13 7:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 20,547 | $10.2 | 272,212 (Direct) | View |
| 2025-11-11 Exercise | 2025-11-13 7:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 44,079 | $14.25 | 272,212 (Direct) | View |
| 2025-11-11 Exercise | 2025-11-13 7:01 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 105,653 | $0 | 272,212 (Direct) | View |
| 2025-11-11 Exercise | 2025-11-13 7:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 6,613 | $15.44 | 272,212 (Direct) | View |
| 2025-11-13 Exercise | 2025-11-13 7:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director | 15,000 | $10.2 | 17,900 (Direct) | View |
| 2025-11-13 Exercise | 2025-11-13 7:01 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director | 15,000 | $0 | 17,900 (Direct) | View |
| 2025-11-11 Exercise | 2025-11-13 7:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Gold Alexander M Director | 24,675 | $10.2 | 71,092 (Direct) | View |
| 2025-11-13 Exercise | 2025-11-13 7:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Gold Alexander M Director | 10,000 | $12.69 | 71,092 (Direct) | View |
| 2025-11-11 Exercise | 2025-11-13 7:01 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Gold Alexander M Director | 34,675 | $0 | 71,092 (Direct) | View |
| 2025-08-12 Exercise | 2025-08-14 6:02 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 175,422 (Direct) | View |
| 2025-08-12 Exercise | 2025-08-14 6:02 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $0 | 175,422 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-15 5:00 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 186,787 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-15 5:00 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $0 | 186,787 (Direct) | View |
| 2025-06-12 Exercise | 2025-06-16 4:03 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 196,880 (Direct) | View |
| 2025-06-12 Exercise | 2025-06-16 4:03 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $0 | 196,880 (Direct) | View |
| 2025-05-12 Exercise | 2025-05-13 8:57 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 219,612 (Direct) | View |
| 2025-05-12 Exercise | 2025-05-13 8:57 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $0 | 219,612 (Direct) | View |
| 2025-04-14 Exercise | 2025-04-15 8:39 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 219,612 (Direct) | View |
| 2025-04-14 Exercise | 2025-04-15 8:39 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $0 | 219,612 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 5:36 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 1,606 | $1.08 | 230,978 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 5:36 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 1,606 | $0 | 230,978 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-13 5:15 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 286,749 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-13 5:15 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $0 | 286,749 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 9:41 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 32,900 | $0 | 32,900 (Indirect) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 170,000 | $0 | 170,000 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 170,000 | $0 | 170,000 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner | 32,900 | $0 | 32,900 (Direct) | View |
| 2025-02-13 Other | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 65,800 | $0 | 65,800 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 32,900 | $0 | 65,800 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | DiRocco Derek Director | 32,900 | $0 | 32,900 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Gold Alexander M Director | 32,900 | $0 | 32,900 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:58 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 570,000 | $0 | 570,000 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:58 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director | 32,900 | $0 | 32,900 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:58 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | SBLENDORIO GLENN Director | 32,900 | $0 | 32,900 (Direct) | View |
| 2025-02-12 Exercise | 2025-02-13 5:29 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 286,749 (Direct) | View |
| 2025-02-12 Exercise | 2025-02-13 5:29 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $0 | 286,749 (Direct) | View |
| 2025-01-13 Exercise | 2025-01-15 9:45 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 286,749 (Direct) | View |
| 2025-01-13 Exercise | 2025-01-15 9:45 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0.54 | 286,749 (Direct) | View |
| 2025-01-13 Exercise | 2025-01-15 9:45 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,367 | $0 | 286,749 (Direct) | View |